Diabetic nephropathy screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Diabetic nephropathy}} {{CMG}};{{AE}} {{AN}} ==Overview== Microalbumin levels in the urine is an excellent tool to look for early damage to kidneys secondary to [..." |
No edit summary |
||
| Line 7: | Line 7: | ||
==Screening== | ==Screening== | ||
* [[Screening]] for nephropathy in diabetes should begin at the time of diagnosis of [[type II diabetes mellitus]]. | |||
* Minute levels of [[albumin]] in the urine are not detectable with routine urine protein dipsticks. | * Minute levels of [[albumin]] in the urine are not detectable with routine urine protein dipsticks. | ||
* | |||
Revision as of 20:51, 24 January 2013
|
Diabetic nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diabetic nephropathy screening On the Web |
|
American Roentgen Ray Society Images of Diabetic nephropathy screening |
|
Risk calculators and risk factors for Diabetic nephropathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
Microalbumin levels in the urine is an excellent tool to look for early damage to kidneys secondary to diabetes. Albumin is a protein found normally in the serum, but it gets completely absorbed from the renal tubules when it is filtered into the nephron from the glomerulus. Hence, a damaged nephron will not reabsorb the albumin filtered by the glomerulus and it appears in the urine.
Screening
- Screening for nephropathy in diabetes should begin at the time of diagnosis of type II diabetes mellitus.
- Minute levels of albumin in the urine are not detectable with routine urine protein dipsticks.